|1.||Eliez, Stephan: 24 articles (05/2015 - 11/2005)|
|2.||McDonald-McGinn, Donna M: 21 articles (12/2015 - 08/2003)|
|3.||Bassett, Anne S: 21 articles (05/2015 - 04/2008)|
|4.||Kates, Wendy R: 19 articles (12/2015 - 02/2005)|
|5.||Simon, Tony J: 16 articles (09/2015 - 09/2004)|
|6.||Gothelf, Doron: 16 articles (08/2015 - 11/2005)|
|7.||Chow, Eva W C: 16 articles (05/2015 - 04/2008)|
|8.||Antshel, Kevin M: 15 articles (04/2015 - 04/2005)|
|9.||Debbané, Martin: 15 articles (11/2014 - 01/2006)|
|10.||Zackai, Elaine H: 15 articles (08/2014 - 10/2003)|
|1.||Schizophrenia (Dementia Praecox)
08/01/2014 - "The aim of the present study was to investigate whether adolescents affected by the 22q11.2 deletion syndrome (22q11DS), known to have a 30 fold increased risk to develop schizophrenia, already show deviant EEG microstates. "
04/30/2012 - "In the present study, we aimed to replicate these results in a sample of participants with 22q11.2 deletion syndrome (22q11DS), a neurogenetic condition associated with high risk of developing schizophrenia. "
04/01/2012 - "In this study, we investigated the neural bases of self- and other-related processing in typically developing adolescents and youths with 22q11.2 deletion syndrome (22q11DS), a rare neurogenetic condition associated with difficulties in social interactions and increased risk for schizophrenia. "
05/01/2011 - "These structural MRI findings in a 22q11.2 deletion syndrome form of schizophrenia are consistent with those from studies involving schizophrenia samples from the general population. "
05/01/2011 - "Previous imaging studies have provided limited data on the relation of schizophrenia expression in 22q11.2 deletion syndrome to specific regional brain volumetric changes. "
|2.||DiGeorge Syndrome (Syndrome, DiGeorge)
11/21/2013 - "Moreover, we applied our approach to identify connect-ability defects in neurons from a mouse model of 22q11.2 deletion syndrome/DiGeorge syndrome, by comparative trials with wild type preparations. "
12/01/2009 - "Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome)."
02/01/2005 - "This study examined memory functioning in children and adolescents with 22q11.2 Deletion Syndrome (DS; velocardiofacial syndrome). "
09/01/2015 - "Social cognition dysfunction in adolescents with 22q11.2 deletion syndrome (velo-cardio-facial syndrome): relationship with executive functioning and social competence/functioning."
07/01/2015 - "Chromosome 22q11.2 deletion syndrome, or DiGeorge syndrome, or velocardiofacial syndrome, is one of the most common multiple anomaly syndromes in humans. "
12/01/2015 - "Clinical manifestations and frequency of hypocalcemia in 22q11.2 deletion syndrome."
01/01/2014 - "TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia."
01/01/2014 - "Hypocalcemia is a common endocrinological condition in 22q11.2 deletion syndrome. "
04/01/2013 - "Patients with 22q11.2 deletion syndrome have heterogeneous clinical presentations including immunodeficiency, cardiac anomalies, and hypocalcemia. "
12/01/2015 - "This study investigated the evolution of hypocalcemia with age and its associated risk factors in patients with 22q11.2 deletion syndrome (22qDS) and congenital heart defects. "
|4.||Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/01/2015 - "The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome."
09/01/2015 - "The 22q11.2 deletion syndrome (22q11DS; velo-cardio-facial syndrome) is associated with an increased risk of various disorders, including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). "
11/01/2012 - "The goal of this trial was to assess the feasibility and safety of using S-adenosyl-L-methionine (SAMe) to treat depressive disorder, attention deficit/hyperactivity disorder (ADHD) and cognitive deficits in individuals with the 22q11.2 deletion syndrome (22q11.2DS). "
09/01/2013 - "Space limits preclude the coverage of all neurodevelopmental disorders; instead, we cover a representative selection of studies examining neural correlates of autism, attention deficit/hyperactivity disorder, Fragile X, 22q11.2 deletion syndrome, Williams syndrome, Down syndrome, and Turner syndrome. "
|5.||Congenital Heart Defects (Congenital Heart Defect)
07/01/2015 - "The 22q11.2 deletion syndrome (DS) is a common multiple anomaly syndrome in which typical features include congenital heart defects, facial dysmorphism, and palatal anomalies. "
05/01/2015 - "Although ranked among the least common congenital heart defects, TA provides an excellent model for the role of individual genes in cardiac morphogenesis as exemplified by TBX1 deficiency caused by point mutations or, more commonly, hemizygosity as part of the 22q11.2 deletion syndrome. "
03/15/2015 - "Outflow tract (OFT) malformation accounts for ∼30% of human congenital heart defects and manifests frequently in TBX1 haplo-insufficiency associated DiGeorge (22q11.2 deletion) syndrome. "
10/10/2014 - "Our results provide new insights into the pathogenesis of congenital heart defects and 22q11.2 deletion syndrome phenotypes."
10/10/2014 - "To evaluate the role of TBX1, the major gene implicated in congenital heart defects in 22q11.2 deletion syndrome patients, in posterior SHF development. "
|1.||Biological Markers (Surrogate Marker)
|4.||Catechol O-Methyltransferase (Methyltransferase, Catechol)
|7.||Transcription Factors (Transcription Factor)
|8.||Antipsychotic Agents (Antipsychotics)
|9.||T-Cell Antigen Receptors (T-Cell Receptor)
|10.||Shprintzen VCF syndrome
|2.||Drug Therapy (Chemotherapy)